Literature DB >> 2487144

Molecular differential pathology of rhabdomyosarcoma.

H Scrable1, D Witte, H Shimada, T Seemayer, W W Sheng, S Soukup, A Koufos, P Houghton, B Lampkin, W Cavenee.   

Abstract

Tumors of the soft tissues are classified histogenetically according to their phenotypic resemblance to normal adult tissue. Here we describe molecular approaches that make it possible to distinguish between one class of these tumors, rhabdomyosarcoma, and other small-, round-cell tumors. We show that the ascertainment of specific genotypic changes can be used to distinguish further between the embryonal and alveolar subtypes of rhabdomyosarcoma. We tested our model in two ways: first, in a retrospective analysis of diagnostically problematic cases of undifferentiated, small-cell tumors and, second, in a blind study of pediatric tumors. Rhabdomyosarcoma was correctly identified in all cases using this strategy alone. The underlying simplicity of the strategy used to define rhabdomyosarcoma subtypes with molecular markers suggests a model by which tumors can be unequivocally identified, which may apply equally well to other human solid tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487144     DOI: 10.1002/gcc.2870010106

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  40 in total

Review 1.  Diagnosis and classification of the small round-cell tumors of childhood.

Authors:  S L Cohn
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

Authors:  A Pandita; M Zielenska; P Thorner; J Bayani; R Godbout; M Greenberg; J A Squire
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.

Authors:  J Anderson; A Gordon; A McManus; J Shipley; K Pritchard-Jones
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

4.  Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

Authors:  P Dias; D M Parham; D N Shapiro; B L Webber; P J Houghton
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

5.  Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.

Authors:  L Krsková; M Mrhalová; D Sumerauer; R Kodet
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

6.  Microsatellite instability in childhood rhabdomyosarcoma is locus specific and correlates with fractional allelic loss.

Authors:  M Visser; J Bras; C Sijmons; P Devilee; L C Wijnaendts; J C van der Linden; P A Voûte; F Baas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 7.  Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice.

Authors:  D W Visscher; F H Sarkar; J D Crissman
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

8.  The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.

Authors:  S Gattenloehner; A Vincent; I Leuschner; S Tzartos; H K Müller-Hermelink; T Kirchner; A Marx
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

9.  Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.

Authors:  P Thorner; J Squire; S Chilton-MacNeil; P Marrano; J Bayani; D Malkin; M Greenberg; A Lorenzana; M Zielenska
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.

Authors:  S Ognjanovic; S E Carozza; E J Chow; E E Fox; S Horel; C C McLaughlin; B A Mueller; S Puumala; P Reynolds; J Von Behren; L Spector
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.